Search - tctmd.com

Displaying 441 - 460 of 817

Sort: Relevancy | Date

News Daily News

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

Todd Neale

September 19, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

Presentation ESC 2018

FUnctional Testing Underlying REvascularization The FUTURE trial

Presenter: Gilles Rioufol

August 26, 2018

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Todd Neale

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Daily News

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Michael O'Riordan

August 14, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Todd Neale

August 01, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Conference News SCCT 2018

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Yael L. Maxwell

July 18, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Advertisement

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

TCTMD’s Top 10 Most Popular Stories for August 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

FUnctional Testing Underlying REvascularization The FUTURE trial

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content